{"celex_id": "31994R2701", "uri": "http://publications.europa.eu/resource/cellar/9c6e9356-cbc7-4fe9-be4a-64ca4efd0414", "type": "Regulation", "concepts": ["1442", "192", "2737", "2785", "343", "3813"], "title": "Commission Regulation (EC) No 2701/94 of 7 November 1994 amending Annexes I, II, III and IV to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance)\n", "header": "8.11.1994 EN Official Journal of the European Communities L 287/7\nCOMMISSION REGULATION (EC) NO 2701/94\nof 7 November 1994\namending Annexes I, II, III and IV to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin\n(Text with EEA relevance)\nTHE COMMISSION OF THE EUROPEAN COMMUNITIES", "recitals": ",\nHaving regard to the Treaty establishing the European Community,\nHaving regard to Council Regulation (EEC) No 2377/90 of 26 June 1990 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin\u00a0(1), as last amended by Commission Regulation (EC) No 1430/94\u00a0(2), and in particular Articles 6, 7 and 8 thereof,\nWhereas, since the adoption of the Regulation, the Annexes have been amended a number of times; whereas, by reason of their number, their complexity and their dispersal among various Official Journals of the European Communities, the texts are difficult to use and thus lack the clarity which should be an essential feature of all legislation; whereas, they should therefore be consolidated; whereas on the same occasion the name or chemical description of some compounds should be rectified or made more precise and certain material errors should be corrected;\nWhereas the measures provided for in this Regulation are in accordance with the opinion of the Committee for the adaptation to technical progress of directives on the removal of technical barriers to trade in the veterinary medicinal products sector,", "main_body": ["Annexes I, II, III and IV to Regulation (EEC) No 2377/90 are hereby amended as set out in the Annex hereto.", "This Regulation shall enter into force on the 60th day following its publication in the Official Journal of the European Communities.\nThis Regulation shall be binding in its entirety and directly applicable in all Member States."], "attachments": "Done at Brussels, 7 November 1994.\nFor the Commission\nMartin BANGEMANN\nMember of the Commission\n(1)\u00a0\u00a0OJ No L 224, 18. 8. 1990, p. 1.\n(2)\u00a0\u00a0OJ No L 156, 23. 6. 1994, p. 6.\nANNEX\nANNEX I\nList of pharmacologically active substances for which maximum residue limits have been fixed\n1. Anti-infectious agents\n1.1. Chemotherapeutics\n1.1.1. Sulfonamides\nPharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions\nAll substances belonging to the sulfonamide group Parent drug All food producing species 100 \u03bcg/kg Muscle, liver, kidney, fat The combined total residues of all substances within the sulfonamide group should not exceed 100 \u03bcg/kg\n1.2. Antibiotics\n1.2.1. Penicillins\nPharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions\n1.2.1.1. Benzylpenicillin\n4 \u03bcg/kg Milk\n1.2.1.2. Ampicillin\n4 \u03bcg/kg Milk\n1.2.1.3. Amoxicillin\n4 \u03bcg/kg Milk\n1.2.1.4. Oxacillin\n30 \u03bcg/kg Milk\n1.2.1.5. Cloxacillin\n30 \u03bcg/kg Milk\n1.2.1.6. Dicloxacillin\n30 \u03bcg/kg Milk\n1.2.2. Cephalosporins\nPharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions\n1.2.2.1. Cefquinome\n100 \u03bcg/kg Liver\n50 \u03bcg/kg Muscle\n50 \u03bcg/kg Fat\n1.2.3. Quinolones\nPharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions\n1.2.3.1. Enrofloxacin\n1.2.4. Macrolides\nPharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions\n1.2.4.1. Tilmicosin Tilmicosin Bovine 1\u00a0000 \u03bcg/kg Liver, kidney\n50 \u03bcg/kg Muscle, fat\n2. Antiparasitic agents\n2.1. Agents acting against endoparasites\n2.1.1. Avermectins\nPharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions\n2.1.1.1. Ivermectin\n40 \u03bcg/kg Fat\nPorcine 15 \u03bcg/kg Liver\nOvine 20 \u03bcg/kg Fat\nEquidae\n2.1.1.2. Abamectin\n10 \u03bcg/kg Fat\n2.1.1.3. Doramectin\n25 \u03bcg/kg Fat\n2.1.2 Salicylanilides\nPharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions\n2.1.2.1. Closantel\n3\u00a0000 \u03bcg/kg Kidney, fat\nOvine 1\u00a0500 \u03bcg/kg Muscle, liver\n5\u00a0000 \u03bcg/kg Kidney, fat\n2\u00a0000 \u03bcg/kg\nANNEX II\nList of substances not subject to maximum residue limits\n1. Inorganic chemicals\nPharmacologically active substance(s) Animal species Other provisions\n1.1. Hydrogen peroxide\n1.2. Sulphur\nPorcine\nOvine\nCaprine\nEquidae\n1.3. Iodine and iodine inorganic compounds including:\n\u2014 Sodium and potassium \u2014 iodide\n\u2014 Sodium and potassium \u2014 iodate\n\u2014 Iodophors including polyvinylpyrrolidone \u2014 iodine\n1.4. Sodium chlorite\n2. Organic compounds\nPharmacologically active substance(s) Animal species Others provisions\n2.1. Etiproston tromethamine\nPorcine\n2.2. Ketanserin tartrate\n2.3. Fertirelin acetate\n2.4. Human menopausal urinary gonadotrophin\n2.5. Lactic acid\n2.6. Melatonin\nCaprine\n2.7. Iodine organic compounds\n\u2014 Iodoform\n2.8. Acetyl cysteine\nANNEX III\nList of pharmacologically active substances used in veterinary medicinal products for which provisional maximum residue limits have been fixed\n1. Anti-infectious agents\n1.1. Chemotherapeutics\n1.1.1. Sulfonamides\nPharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions\nAll substances belonging to the sulfonamide group Parent drug Bovine, ovine, caprine 100 \u03bcg/kg Milk Provisional MRL expires on 1. 1. 1996. The combined total residues of all substances within the sulfonamide group should not exceed 100 \u03bcg/kg\n1.1.2. Diamino pyrimidine derivates\nPharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions\n1.1.2.1. Trimethoprim\n1.1.3. Nitrofurans\nPharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions\n1.1.3.1. Furazolidone\n1.1.4. Nitroimidazoles\nPharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions\n1.1.4.1. Dimetridazole\n1.2. Antibiotics\n1.2.1. Tetracyclines\nPharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions\nAll substances belonging to the tetracycline group Parent drug All food producing species 600 \u03bcg/kg Kidney Provisional MRLs expire on 1. 1. 1996. The combined total residues of all substances within the tetracycline group should not exceed the limits indicated\n300 \u03bcg/kg Liver\n200 \u03bcg/kg Eggs\n100 \u03bcg/kg Muscle\n100 \u03bcg/kg Milk\n1.2.2. Macrolides\nPharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions\n1.2.2.1. Spiramycin\n200 \u03bcg/kg Kidney,\n50 \u03bcg/kg Muscle\nBovine 150 \u03bcg/kg Milk\n1.2.2.2. Tylosin Bovine 100 \u03bcg/kg Muscle, liver, kidney Provisional MRLs expire on 1. 7. 1995\nPorcine\nPoultry\nBovine 50 \u03bcg/kg Milk\n1.2.3. Thiamphenicol and related compounds\nPharmacologically active substance(s) Market residue Animal species MRLs Target tissues Other provisions\n1.2.3.1. Thiamphenicol\n2. Antiparasitic agents\n2.1. Agents acting against endo-parasites\n2.1.1. Benzimidazoles and pro-benzimidazoles\nPharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions\n2.1.1.1. Febantel\n10 \u03bcg/kg Muscle, kidney, fat\n10 \u03bcg/kg Milk\n2.1.1.2. Fenbendazole\n10 \u03bcg/kg Muscle, kidney, fat\n10 \u03bcg/kg Milk\n2.1.1.3. Oxfendazole\n10 \u03bcg/kg Muscle, kidney, fat\n10 \u03bcg/kg Milk\n2.1.1.4. Albendazole\nOvine 500 \u03bcg/kg Kidney\n1\u00a0000 \u03bcg/kg Liver\n2.1.1.5. Thiabendazole\nOvine\nCaprine\n2.1.1.6. Triclabendazole\nOvine 50 \u03bcg/kg Fat\n2.1.1.7. Flubendazole\nGame birds 200 \u03bcg/kg Muscle,\n400 \u03bcg/kg Eggs\nPorcine 10 \u03bcg/kg Muscle, liver, kidney, fat\n2.1.1.8. Oxibendazole\n50 \u03bcg/kg Milk\nPorcine 100 \u03bcg/kg Muscle, liver, kidney, fat\n2.1.2. Tetra-hydro-imidazoles (imidazolthiazoles)\nPharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions\n2.1.2.1. Levamisole\n2.2. Agents acting against ectoparasites\nPharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions\n2.2.1. Amitraz\n200 \u03bcg/kg Kidney, liver\n3. Agents acting on the nervous system\n3.1. Agents acting on the central nervous system\n3.1.1. Butyrophenone tranquilizers\nPharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions\n3.1.1.1. Azaperone\n50 \u03bcg/kg1 Liver, muscle, fat\n3.2. Agents acting on the autonomic nervous system\n3.2.1. Anti-adrenergics\nPharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions\n3.2.1.1. Carazolol\n5 \u03bcg/kg Kidney, muscle, fat\nANNEX IV\nList of pharmacologically active substances for which no maximum levels can be fixed\n1. Nitrofurans, except furazolidone (see Annex III)\n2. Ronidazole\n3. Dapsone\n4. Chloramphenicol"}